Bajaj HealthCare Limited (BAJAJHCARE)

431.45

INR
+48.90(+12.78%)
As of December 6, 2024 10:00:00 AM

Bajaj HealthCare Limited Share Price Information

24 hour Low and High

Low: 379.1
High: 388.2

All time High

497.70

Price Change 1h

+₹48.90 +12.78%

Price Change 1d

+₹48.90 +12.78%

Price Change 1w

+₹40.35 +10.32%

Bajaj HealthCare Limited Market Information

Exchange

NSE

Market Cap

1143.16 Cr

About Bajaj HealthCare Limited Share

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1049

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Don't Buy Bajaj HealthCare Limited (NSE:BAJAJHCARE) For Its Next Dividend Without Doing These Checks
  • BAJAJ HEALTHCARE Share Price Today Up 6%
  • Bajaj Healthcare gains over 4% on board nod to raise up to ₹137 cr via preferential issue
  • Bajaj Healthcare : Files Compulsory License With Indian Patent Office For Baricitinib
  • Stock Market Highlights: Markets close flat; NIFTY50 at 24,315, SENSEX sheds 27 points

FAQs

Bajaj HealthCare Limited (BAJAJHCARE)

431.45

INR
+48.90(+12.78%)
As of December 6, 2024 10:00:00 AM

Bajaj HealthCare Limited Share Price Information

24 hour Low and High

Low: 379.1
High: 388.2

All time High

497.70

Price Change 1h

+₹48.90 +12.78%

Price Change 1d

+₹48.90 +12.78%

Price Change 1w

+₹40.35 +10.32%

Bajaj HealthCare Limited Market Information

Exchange

NSE

Market Cap

1143.16 Cr

About Bajaj HealthCare Limited Share

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1049

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Don't Buy Bajaj HealthCare Limited (NSE:BAJAJHCARE) For Its Next Dividend Without Doing These Checks
  • BAJAJ HEALTHCARE Share Price Today Up 6%
  • Bajaj Healthcare gains over 4% on board nod to raise up to ₹137 cr via preferential issue
  • Bajaj Healthcare : Files Compulsory License With Indian Patent Office For Baricitinib
  • Stock Market Highlights: Markets close flat; NIFTY50 at 24,315, SENSEX sheds 27 points

FAQs